Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative Ketorolac in High Risk Breast Cancer Patients With and Without Inflammation. A Prospective Randomized Placebo-controlled Trial.

NCT01806259 is registered in ClinicalTrials.gov with Université Catholique de Louvain as lead sponsor.

NCT NCT01806259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01806259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative Ketorolac in High Risk Breast Cancer Patients With and Without Inflammation. A Prospective Randomized Placebo-controlled Trial.
Lead sponsor
Université Catholique de Louvain
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2013
Completion date
September 30, 2018
Enrollment
203 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

curative breast cancer surgery, inflammatory positive/negative status, pre surgical incision administration